logo
Select company
Select metric
$ 0Total Debt
VS
Market
93
Sector
90
Industry
86
History
88
$ 0.74Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information

Ticker

GTBP

Company Name

GT BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GT BIOPHARMA INC - Total Debt Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GTBP - Debt Historical data
DateTotal Debt
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
6/30/2024$ 0
3/31/2024$ 30K
12/31/2023$ 58K
9/30/2023$ 92K
6/30/2023$ 120K
3/31/2023$ 147K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GT BIOPHARMA INC's latest trailing twelve months (TTM) Debt stands at $ 23.11M.
  • Over the past 5 years, GT BIOPHARMA INC's average Debt has been $ 2.54M.
  • The median Debt for GT BIOPHARMA INC during this period was $ 44.5K
  • GT BIOPHARMA INC reached its highest Debt over the past 5 years at $ 26.33M.
  • The lowest Debt recorded by GT BIOPHARMA INC in the same timeframe $ 0

Definition of Total Debt

[Balance Sheet] The total debt is a component of [Liabilities] that represents principle balances held in exchange for interest paid (also know as loans). Includes secured and unsecured bonds issued, commercial paper, notes payable credit facilities, lines of credit, capital lease obligations, operating lease obligations, and convertible notes.

GTBP - Total Debt, Last 5 years

$ 0

Minimum

Jun 30, 2024

$ 26.33M

Maximum

Dec 31, 2020

$ 2.54M

Average

$ 44.5K

Median

Debt Benchmark Analysis

The chart above depicts the distribution of Debt for companies in the Total Stock Market. The average Debt of the companies is $ 183.65M with a standard deviation of $ 277.47M.
The following table provides additional summary stats:
Debt in the Market:
filtered constituents3.17K
min$ 0
max$ 1.15B
average$ 183.65M
median$ 38.04M
std$ 277.47M